[go: up one dir, main page]

ES483236A1 - Pyrazolidine-dione derivatives and their preparation and use in therapy - Google Patents

Pyrazolidine-dione derivatives and their preparation and use in therapy

Info

Publication number
ES483236A1
ES483236A1 ES483236A ES483236A ES483236A1 ES 483236 A1 ES483236 A1 ES 483236A1 ES 483236 A ES483236 A ES 483236A ES 483236 A ES483236 A ES 483236A ES 483236 A1 ES483236 A1 ES 483236A1
Authority
ES
Spain
Prior art keywords
pyrazolidine
therapy
dione derivatives
preparation
dione
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES483236A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Publication of ES483236A1 publication Critical patent/ES483236A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28Two oxygen or sulfur atoms
    • C07D231/30Two oxygen or sulfur atoms attached in positions 3 and 5
    • C07D231/32Oxygen atoms
    • C07D231/36Oxygen atoms with hydrocarbon radicals, substituted by hetero atoms, attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pyrazolidine-dione derivatives of the formula < IMAGE > in which R1 and R2 are the same or different and each is hydrogen or alkyl of 1 to 6 carbon atoms, or R1 and R2 together with the nitrogen to which they are attached form a heterocyclic ring which may or may not contain another hetero-atom which can itself carry a substituent, are useful in therapy as inhibitors of platelet aggregation. They may be made from the corresponding unsubstituted pyrazolidine-dione by a Mannich reaction.
ES483236A 1978-08-09 1979-08-08 Pyrazolidine-dione derivatives and their preparation and use in therapy Expired ES483236A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7823438A FR2433020A1 (en) 1978-08-09 1978-08-09 PYRAZOLIDINE-DIONE DERIVATIVES AND THEIR THERAPEUTIC APPLICATION

Publications (1)

Publication Number Publication Date
ES483236A1 true ES483236A1 (en) 1980-05-16

Family

ID=9211717

Family Applications (1)

Application Number Title Priority Date Filing Date
ES483236A Expired ES483236A1 (en) 1978-08-09 1979-08-08 Pyrazolidine-dione derivatives and their preparation and use in therapy

Country Status (11)

Country Link
JP (1) JPS5524200A (en)
AT (1) AT369735B (en)
BE (1) BE878158A (en)
DE (1) DE2932054A1 (en)
ES (1) ES483236A1 (en)
FR (1) FR2433020A1 (en)
GB (1) GB2028324A (en)
IT (1) IT1122740B (en)
LU (1) LU81582A1 (en)
NL (1) NL7906029A (en)
PT (1) PT70042A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1191034B (en) * 1982-10-15 1988-02-24 Edmondo Pharma Srl COMPOUND WITH VASODILATOR, ANTI-AGGREGATING AND HYPO-COLESTEROLEMIZING ACTIVITY, PROCEDURE FOR ITS PREPARATION AND RELATIVE PHARMACEUTICAL COMPOSITION

Also Published As

Publication number Publication date
NL7906029A (en) 1980-02-12
PT70042A (en) 1979-09-01
AT369735B (en) 1983-01-25
JPS5524200A (en) 1980-02-21
BE878158A (en) 1980-02-11
DE2932054A1 (en) 1980-02-21
GB2028324A (en) 1980-03-05
IT7924997A0 (en) 1979-08-08
FR2433020B1 (en) 1980-12-05
LU81582A1 (en) 1981-03-24
IT1122740B (en) 1986-04-23
FR2433020A1 (en) 1980-03-07
ATA539279A (en) 1982-06-15

Similar Documents

Publication Publication Date Title
ES482256A1 (en) Reactive dyes, processes for their manufacture and use thereof
ES422395A1 (en) Aromatic carboxylic amide derivatives
ES405983A1 (en) N-fluoroalkylated phenylethylamine
ES459412A1 (en) Heterocyclic compound
ES466143A1 (en) Novel imidazoquinolines
ES473925A1 (en) Tetrapeptides, methods for their preparation and their use in analgesic compositions.
ZA858418B (en) 5-alkyl-1-phenyl-2-piperazinoalkylpyrazoline-3-one compounds and methods for the preparation thereof,intermediates for use in the preparation of said compounds and medicaments containing said compounds
SE7613304L (en) PROCEDURE FOR THE PREPARATION OF 7-METHOXICEPHALOSPORINE
ES422906A1 (en) Derivatives of 2-aminoindane, the preparation and use thereof
ES483236A1 (en) Pyrazolidine-dione derivatives and their preparation and use in therapy
ES8101071A1 (en) 2-(Pyrid-2-yl)tetrahydrothiophene derivatives
ES427115A1 (en) Novel benzoylphenylacetic acid derivatives
ES419019A1 (en) Indolo-2,3-c quinolinone derivatives
IE791781L (en) 4, 5-methano-bufadienolide rhamnosides
IE44449L (en) Morphanthridines
ES430131A1 (en) N{40 -(Aminoacylaminophenyl) acetamidines
ES426771A1 (en) Aminopropanol substituted isochromanones and phthalides
GB1512620A (en) Derivatives of dithiepino(1,4)(2,3-c)pyrrole
ES450875A1 (en) 5 -2(-imidazolin -2- ylamino) -213- benzothladiazole derivatives
ES449446A1 (en) 1-Oxo-1H-6-piperidinopyrimido{8 1,2-a{9 quinoline-2-carboxylic acids and esters
IE41906L (en) But-2-enoanilides
IE35788L (en) 1, 5-benzodiazepinones.
ZA794486B (en) Clavulanic acid derivatives,their preparation and use
ES496256A1 (en) Pyridine derivatives, processes for their preparation and their use.
ES8307812A1 (en) Beta-lactam antibacterial agents, their preparation and use.